Teknor Apex announces new CEO to replace Jonathan Fain
18 Sep 2023
Executive ChangeAcquisition
Donald Wiseman takes over as CEO of Teknor Apex as Jonathan Fain steps down.
For the past 51 years, Jonathan Fain has led Teknor Apex to develop long term partnerships with the company’s suppliers and customers in order to build a build a strong resilient company.
During his tenure, the company revenue has grown by more than 650%, expanded beyond North America to a global footprint, and completed eleven acquisitions.
Fain has decided to step aside as CEO of the company. He will remain a major stakeholder and continue serving as chairman of the Board; a position he assumed from his father. “I have had the privilege and honour to lead a great company for over 50 years, and while I am not retiring, I do want to hand over the day-to-day responsibility to someone who can drive to keep the company strong, growing and build upon our culture,” says Fain. “I am very confident in our future leadership and plans for supporting our growth, innovation and sustainability for years to come. Don brings a wealth of experience and is an ideal fit into our company and culture.”
The new Teknor Apex CEO, Donald Wiseman, has a robust history within the plastics industry and a deep expertise in masterbatches and compounding. Most recently he held the position of CEO at Star Plastics. Previously, he was the president for performance products and solutions with PolyOne, managing director and general manager in Taiwan for Cabot Microelectronics, and various leadership roles at Americhem. He will be relocating from Cleveland to work out of the Teknor Apex Headquarters in Pawtucket RI. “I am very excited to join the leadership team of Teknor Apex. What began almost 100 years ago as a small venture in Rhode Island is now among the world’s leading custom compounders. I firmly believe that people and culture are a true competitive advantage for Teknor. I will demonstrate this by removing barriers, collaborating, and rewarding performance to ambitious goals and solve the most demanding business problems, all while emerging a more robust team,” Wiseman said.
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Indications
-Targets
-Drugs
-Chat with Hiro
Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.